Xylem Inc (XYL) Position Lowered by Baker Chad R
Baker Chad R lessened its position in shares of Xylem Inc (NYSE:XYL) by 19.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,625 shares of the industrial products company’s stock after selling 22,550 shares during the quarter. Xylem comprises 2.3% of Baker Chad R’s holdings, making the stock its 15th biggest position. Baker Chad R owned 0.05% of Xylem worth $5,863,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of XYL. Invictus RG purchased a new stake in Xylem during the 3rd quarter worth approximately $104,000. Harfst & Associates Inc. grew its position in Xylem by 26.1% during the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after purchasing an additional 503 shares during the last quarter. Tower Research Capital LLC TRC purchased a new stake in Xylem during the 2nd quarter worth approximately $168,000. FNY Partners Fund LP grew its position in Xylem by 2,700.0% during the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after purchasing an additional 2,700 shares during the last quarter. Finally, Federated Investors Inc. PA grew its position in Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after purchasing an additional 181 shares during the last quarter. Hedge funds and other institutional investors own 85.57% of the company’s stock.
Several analysts have weighed in on the stock. Canaccord Genuity reissued a “hold” rating and set a $65.00 target price on shares of Xylem in a research report on Monday. Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Wednesday, December 6th. Seaport Global Securities reissued a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Oppenheimer boosted their target price on shares of Xylem from $66.00 to $75.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 1st. Finally, BMO Capital Markets boosted their target price on shares of Xylem from $74.00 to $76.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 1st. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Xylem currently has an average rating of “Buy” and a consensus target price of $65.17.
Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.64 by $0.01. The business had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.18 billion. Xylem had a net margin of 6.85% and a return on equity of 17.74%. The business’s revenue for the quarter was up 33.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.54 EPS. equities analysts forecast that Xylem Inc will post 2.39 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 6th. Stockholders of record on Thursday, November 2nd were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 1.07%. The ex-dividend date was Wednesday, November 1st. Xylem’s dividend payout ratio (DPR) is currently 41.86%.
In other news, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the sale, the insider now directly owns 61,979 shares of the company’s stock, valued at approximately $4,078,837.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the completion of the sale, the director now directly owns 58,831 shares in the company, valued at $3,897,553.75. The disclosure for this sale can be found here. Insiders sold a total of 83,270 shares of company stock worth $5,501,312 over the last ninety days. Insiders own 0.75% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/12/12/xylem-inc-xyl-position-lowered-by-baker-chad-r.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Stock Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related stocks with our FREE daily email newsletter.